40

N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity

  • Upload
    others

  • View
    11

  • Download
    0

Embed Size (px)

Citation preview

Page 1: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 2: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 3: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 4: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 5: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 6: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 7: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 8: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 9: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 10: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 11: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 12: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 13: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 14: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 15: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 16: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 17: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 18: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 19: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 20: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 21: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 22: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 23: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 24: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 25: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 26: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 27: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 28: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 29: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 30: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 31: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 32: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 33: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 34: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 35: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 36: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 37: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 38: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 39: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 40: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity